Coherus Oncology, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
1.285
-0.025 (-1.91%)
Sep 5, 2025, 3:01 PM - Market open
Coherus Oncology Market Cap
Coherus Oncology has a market cap or net worth of $149.35 million as of September 5, 2025. Its market cap has increased by 2.51% in one year.
Market Cap
149.35M
Enterprise Value
-38.54M
1-Year Change
2.51%
Ranking
Category
Stock Price
$1.29
Market Cap Chart
Since November 6, 2014, Coherus Oncology's market cap has decreased from $404.20M to $149.35M, a decrease of -63.05%. That is a compound annual growth rate of -8.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2025 | 152.30M | -4.21% |
| Dec 31, 2024 | 159.00M | -57.12% |
| Dec 29, 2023 | 370.80M | -39.81% |
| Dec 30, 2022 | 616.00M | -49.73% |
| Dec 31, 2021 | 1.23B | -2.13% |
| Dec 31, 2020 | 1.25B | -0.83% |
| Dec 31, 2019 | 1.26B | 105.12% |
| Dec 31, 2018 | 615.60M | 20.73% |
| Dec 29, 2017 | 509.90M | -58.50% |
| Dec 30, 2016 | 1.23B | 37.60% |
| Dec 31, 2015 | 893.00M | 64.52% |
| Dec 31, 2014 | 542.80M | 34.29% |
| Nov 6, 2014 | 404.20M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 662.38B |
| Johnson & Johnson | 428.68B |
| AbbVie | 374.26B |
| UnitedHealth Group | 278.84B |
| AstraZeneca | 254.65B |
| Novo Nordisk | 253.55B |
| Novartis AG | 248.54B |
| Abbott Laboratories | 230.05B |